5 Einträge gefunden

1. A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis

   1. Pinter, A
   2. Green, L J
   3. Selmer, J
   4. Praestegaard, M
   5. Gold, L S
   6. Augustin, M

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)

   1. Pinter, A
   2. Hoffmann, M
   3. Reich, K
   4. Augustin, M
   5. Kaplan, K
   6. Gudjónsdóttir, S D
   7. Delvin, T

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment

   1. Leutz, A
   2. Pinter, A
   3. Thaçi, D
   4. Augustin, M
   5. Schuster, C
   6. Fotiou, K
   7. Hundemer, H P

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. A 24-week multicentre, randomized, open-label, parallel-group study comparing the efficacy and safety of ixekizumab vs. fumaric acid esters and methotrexate in patients with moderate-to-severe plaque psoriasis naive to systemic treatment

   1. Reich, K
   2. Augustin, M
   3. Thaçi, D
   4. Pinter, A
   5. Leutz, A
   6. Henneges, C
   7. Schneider, E

   2020 - Forschungsinformationssystem des UKE
5. Continued treatment with secukinumab is associated with high retention or regain of response

   1. Augustin, M
   2. Thaci, D
   3. Eyerich, K
   4. Pinter, A
   5. Radtke, M
   6. Lauffer, F
   7. Mrowietz, U

   2020 - Forschungsinformationssystem des UKE